Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00115
|
|||||
Drug Name |
Lysine
|
|||||
Synonyms |
Enisyl
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Schizophrenia [ICD11:6A20] | preclinical | [1] | |||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C6H14N2O2
|
|||||
Canonical SMILES |
C(CCN)CC(C(=O)O)N
|
|||||
InChI |
InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1
|
|||||
InChIKey |
KDXKERNSBIXSRK-YFKPBYRVSA-N
|
|||||
CAS Number |
CAS 56-87-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 146.19 | Topological Polar Surface Area | 89.3 | ||
Heavy Atom Count | 10 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
-3
|
|||||
PubChem CID | ||||||
PubChem SID |
10527684
,14719441
,15219170
,15321566
,17486473
,22435038
,24896404
,24896515
,24901905
,26708216
,29224985
,3152007
,3349
,46392835
,46393686
,46504770
,46506741
,48416191
,49854144
,49989434
,53776958
,53776966
,53776972
,53776985
,53776989
,53776992
,53776997
,56260873
,56269965
,57304237
,57304479
,57323083
,57580879
,57651911
,6436589
,77923504
,7849363
,81044533
,81055044
,81065730
,8144553
,8153705
,819792
,824263
,824970
,829089
,836276
,837782
,837797
,837799
|
|||||
ChEBI ID |
ChEBI:18019
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | ORNT3 | Transporter Info | Mitochondrial ornithine transporter 3 | Substrate | [2] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | ORNT3 | Transporter Info | Km =710 microM | SLC25A29-reconstituted Liposomes | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT00996242) An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia | |||||
2 | The human gene SLC25A29, of solute carrier family 25, encodes a mitochondrial transporter of basic amino acids. J Biol Chem. 2014 May 9;289(19):13374-84. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.